Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Core Insights - Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies [3] - The company will have its President and CEO, Steven Kelly, participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on December 5th at 9:35 am ET [1] - An audio webcast of the event will be available on the company's Investor Relations webpage and archived for a limited time [2] Company Overview - Carisma Therapeutics utilizes a proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies for cancer and other serious diseases [3] - The company is headquartered in Philadelphia, PA [3] - For more information, the company’s website is www.carismatx.com [3]